Vanguard Group Inc Aspira Women'S Health Inc. Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.3 - $0.41 $412 - $564	1,376 Added 0.05%	2,724,506 $899,000
Q3 2022 Nov 14, 2022	BUY	$0.38 - $1.07 $41,033 - $115,542	107,984 Added 4.13%	2,723,130 $1.01 Million
Q2 2022 Aug 12, 2022	SELL	$0.4 - $1.09 $181,100 - $493,497	-452,750 Reduced 14.76%	2,615,146 $1.54 Million
Q1 2022 May 13, 2022	BUY	$0.88 - $1.81 $144,878 - $297,989	164,635 Added 5.67%	3,067,896 $3.19 Million
Q4 2021 Feb 14, 2022	SELL	$1.63 - $3.43 $195,360 - $411,095	-119,853 Reduced 3.96%	2,903,261 $5.14 Million
Q3 2021 Nov 12, 2021	BUY	$3.19 - $5.48 $125,373 - $215,374	39,302 Added 1.32%	3,023,114 $9.83 Million
Q2 2021 Aug 13, 2021	BUY	$4.78 - $6.84 $14.3 Million - $20.4 Million	2,983,812 New	2,983,812 $16.8 Million

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.